Index -
P/E -
EPS (ttm) -2.59
Insider Own 36.41%
Shs Outstand 29.74M
Perf Week -1.00%
Market Cap 59.36M
Forward P/E -
EPS next Y -2.75
Insider Trans -2.84%
Shs Float 18.97M
Perf Month -17.08%
Income -66.03M
PEG -
EPS next Q -0.61
Inst Own 52.98%
Short Float 3.66%
Perf Quarter -33.67%
Sales 0.00M
P/S -
EPS this Y 10.80%
Inst Trans 0.77%
Short Ratio 2.65
Perf Half Y -87.81%
Book/sh 3.71
P/B 0.54
EPS next Y -12.44%
ROA -62.19%
Short Interest 0.69M
Perf Year -64.53%
Cash/sh 3.83
P/C 0.52
EPS next 5Y -
ROE -68.38%
52W Range 1.92 - 22.22
Perf YTD -90.29%
Dividend Est. -
P/FCF -
EPS past 5Y -73.03%
ROI -59.70%
52W High -91.04%
Beta -0.12
Dividend TTM -
Quick Ratio 10.91
Sales past 5Y 0.00%
Gross Margin -
52W Low 3.65%
ATR (14) 0.13
Dividend Ex-Date Apr 12, 2018
Current Ratio 10.91
EPS Y/Y TTM -3.27%
Oper. Margin 0.00%
RSI (14) 27.31
Volatility 5.92% 5.20%
Employees 41
Debt/Eq 0.00
Sales Y/Y TTM -
Profit Margin -
Recom 2.20
Target Price 4.33
Option/Short No / Yes
LT Debt/Eq 0.00
EPS Q/Q 29.36%
Payout -
Rel Volume 5.99
Prev Close 2.04
Sales Surprise -
EPS Surprise 9.68%
Sales Q/Q -
Earnings May 14 AMC
Avg Volume 261.63K
Price 1.99
SMA20 -13.17%
SMA50 -24.23%
SMA200 -82.65%
Trades
Volume 1,566,876
Change -2.45%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-02-24 Upgrade
JMP Securities
Mkt Perform → Mkt Outperform
$6
Feb-13-24 Downgrade
Leerink Partners
Outperform → Market Perform
$23 → $7
Feb-12-24 Downgrade
Oppenheimer
Outperform → Perform
Feb-12-24 Downgrade
JMP Securities
Mkt Outperform → Mkt Perform
Feb-12-24 Downgrade
Evercore ISI
Outperform → In-line
$25 → $7
Jan-04-24 Initiated
JMP Securities
Mkt Outperform
$30
Jul-18-22 Resumed
Oppenheimer
Outperform
$22
May-21-24 09:35AM
May-14-24 10:55PM
04:01PM
Mar-28-24 11:53PM
04:10PM
07:00AM
Loading…
Mar-22-24 07:00AM
Feb-22-24 04:21AM
Feb-12-24 10:03AM
07:04AM
06:54AM
06:45AM
Jan-30-24 04:10PM
Jan-12-24 03:02AM
Jan-10-24 08:50AM
Nov-09-23 04:05PM
08:50AM
Loading…
Nov-06-23 08:50AM
07:00AM
Oct-18-23 07:00AM
Oct-11-23 12:01AM
Sep-27-23 09:40AM
Sep-26-23 07:00AM
Sep-13-23 07:00AM
Sep-11-23 09:40AM
Aug-15-23 10:42PM
Aug-10-23 04:10PM
Jun-14-23 08:55AM
May-25-23 04:10PM
May-18-23 07:00AM
May-11-23 04:10PM
May-09-23 06:05AM
07:00AM
Loading…
May-01-23 07:00AM
Mar-29-23 04:01PM
Feb-28-23 04:10PM
Jan-31-23 04:10PM
Dec-04-22 08:40AM
Nov-09-22 04:05PM
Nov-02-22 04:10PM
Oct-19-22 08:00AM
Oct-06-22 07:00AM
Sep-29-22 07:00AM
Aug-29-22 07:00AM
Aug-11-22 04:10PM
Aug-08-22 11:42AM
Jul-01-22 10:39AM
(American City Business Journals) +5.29%
Jun-29-22 07:00AM
Jun-27-22 09:19AM
May-10-22 04:10PM
May-09-22 07:00AM
Apr-18-22 09:30AM
(American City Business Journals) +5.49%
Mar-28-22 10:33AM
(American City Business Journals)
Mar-25-22 04:40PM
03:06PM
Mar-24-22 10:32PM
02:11PM
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zakrzewski Joseph S Director Jan 18 '24 Sale 19.11 100,000 1,911,410 405,880 Jan 19 07:32 PM Aziz Kabeer Director Jan 16 '24 Sale 19.65 100,000 1,965,000 377,542 Jan 18 06:19 PM Adjuvant Global Health Technol 10% Owner Jan 16 '24 Sale 19.65 84,093 1,652,427 1,995,958 Jan 18 06:18 PM Adjuvant Global Health Technol 10% Owner Jan 16 '24 Sale 19.65 15,907 312,573 377,542 Jan 18 06:18 PM Readnour Robin Shane Director Jan 12 '24 Sale 21.91 1,425 31,229 414,788 Jan 17 05:03 PM Readnour Robin Shane Director Jan 10 '24 Sale 21.93 3,669 80,443 415,494 Jan 12 05:08 PM Krause Kevin Michael Chief Strategy Officer Jan 09 '24 Option Exercise 4.59 7,417 34,015 9,331 Jan 11 07:59 PM Krause Kevin Michael Chief Strategy Officer Jan 09 '24 Sale 20.14 7,417 149,367 1,914 Jan 11 07:59 PM Krause Kevin Michael Chief Strategy Officer Jan 02 '24 Option Exercise 0.42 2,583 1,085 4,497 Jan 04 06:06 PM Easom Eric Chief Executive Officer Jan 02 '24 Sale 20.09 2,777 55,802 2,130 Jan 04 06:05 PM Krause Kevin Michael Chief Strategy Officer Jan 02 '24 Sale 20.12 2,583 51,967 1,914 Jan 04 06:06 PM Aziz Kabeer Director Nov 14 '23 Sale 16.15 1,810 29,224 393,449 Nov 16 06:57 PM Adjuvant Global Health Technol 10% Owner Nov 14 '23 Sale 16.15 1,522 24,574 2,080,051 Nov 16 06:59 PM Adjuvant Global Health Technol 10% Owner Nov 14 '23 Sale 16.15 288 4,650 393,449 Nov 16 06:59 PM Aziz Kabeer Director Oct 02 '23 Sale 16.07 5,672 91,149 393,737 Oct 03 07:21 PM Adjuvant Global Health Technol 10% Owner Oct 02 '23 Sale 16.07 4,770 76,654 2,081,573 Oct 03 07:13 PM Adjuvant Global Health Technol 10% Owner Oct 02 '23 Sale 16.07 902 14,495 393,737 Oct 03 07:13 PM Aziz Kabeer Director Sep 29 '23 Sale 16.28 99,101 1,613,364 394,639 Oct 03 07:21 PM Adjuvant Global Health Technol 10% Owner Sep 29 '23 Sale 16.28 83,337 1,356,726 2,086,343 Oct 03 07:13 PM Adjuvant Global Health Technol 10% Owner Sep 29 '23 Sale 16.28 15,764 256,638 394,639 Oct 03 07:13 PM Aziz Kabeer Director Sep 28 '23 Sale 16.11 8,516 137,193 410,403 Sep 29 05:40 PM Adjuvant Global Health Technol 10% Owner Sep 28 '23 Sale 16.11 7,160 115,348 2,169,680 Sep 29 05:41 PM Adjuvant Global Health Technol 10% Owner Sep 28 '23 Sale 16.11 1,356 21,845 410,403 Sep 29 05:41 PM Aziz Kabeer Director Sep 27 '23 Sale 16.07 841 13,515 411,759 Sep 29 05:40 PM Adjuvant Global Health Technol 10% Owner Sep 27 '23 Sale 16.07 707 11,361 2,176,840 Sep 29 05:41 PM Adjuvant Global Health Technol 10% Owner Sep 27 '23 Sale 16.07 134 2,153 411,759 Sep 29 05:41 PM Aziz Kabeer Director Sep 13 '23 Sale 16.00 400 6,400 411,893 Sep 15 05:40 PM Adjuvant Global Health Technol 10% Owner Sep 13 '23 Sale 16.00 336 5,376 2,177,547 Sep 15 05:17 PM Adjuvant Global Health Technol 10% Owner Sep 13 '23 Sale 16.00 64 1,024 411,893 Sep 15 05:17 PM Aziz Kabeer Director Sep 07 '23 Sale 16.05 3,378 54,217 411,957 Sep 08 04:57 PM Adjuvant Global Health Technol 10% Owner Sep 07 '23 Sale 16.05 2,841 45,598 2,177,883 Sep 08 04:59 PM Adjuvant Global Health Technol 10% Owner Sep 07 '23 Sale 16.05 537 8,619 411,957 Sep 08 04:59 PM Aziz Kabeer Director Sep 06 '23 Sale 16.02 3,762 60,267 412,494 Sep 08 04:57 PM Adjuvant Global Health Technol 10% Owner Sep 06 '23 Sale 16.02 3,164 50,687 2,180,724 Sep 08 04:59 PM Adjuvant Global Health Technol 10% Owner Sep 06 '23 Sale 16.02 598 9,580 412,494 Sep 08 04:59 PM Aziz Kabeer Director Aug 23 '23 Sale 16.00 400 6,400 413,092 Aug 25 04:30 PM Adjuvant Global Health Technol 10% Owner Aug 23 '23 Sale 16.00 336 5,376 2,183,888 Aug 25 04:31 PM Adjuvant Global Health Technol 10% Owner Aug 23 '23 Sale 16.00 64 1,024 413,092 Aug 25 04:31 PM RA CAPITAL MANAGEMENT, L.P. 10% Owner Aug 18 '23 Buy 9.00 1,777,778 16,000,002 5,135,683 Aug 22 05:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite